Urologist, Gulhane research and training hospital.,
Aims and Scope
Mathews Journal of Urology and Nephrology (ISSN 2577-1396) — is an open access journal publishes original studies and reports, which provide significance and board impact on a wider audience. The main scope of the journal is in its primary sections of pediatric urology, nephrostomy, uro-oncology, endourology, urologic oncology, reconstructive urology, bladder stones, kidney stone, kidney transplant, kidney cancer, retrograde pyelogram and retrograde ureteral, dialysis, renal replacement therapy, renal transplantation and kidney failure.
Editors and Editorial Board
Editorial process of urology and nephrology journal and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board and journal staff.
Mathews Journal of Urology and Nephrology (MJUN) Print ISSN: 2577-1396 and Online ISSN: 2577-1396 is published Bimonthly, a Volume/year.
Benefits of authors
High Visibility: Mathews Journal of Urology and Nephrology (MJUN) as per open access policy allows maximum visibility of articles published in the journal available across the globe.
Promotion in Social Media: Once the article is published, we provide article alerts and regular email updates to subscribers on our social media platforms.
Speed Publication: Mathews Journal of Urology and Nephrology (MJUN) provides fast publication of the submitted articles with quality review process with the esteem editorial board team and reviewer’s team.
If you are not sure whether your work suitable for this journal, please email us at firstname.lastname@example.org or call us at (Toll-Free) +1 800 369 0052.
Published : 26th August 2019
Author : Abdul Kader Mohiuddin
Citation : Mohiuddin AK. (2019). Lifestyle Issues and Prevention of Recurrent UTIs. Mathews J Urol Nephrol 3(1): e003.
Published : 19th October 2018
Authors : Selcuk Sarikaya1,Cihat Ozcan1,Erdem Ozturk2,Nurullah Hamidi3
Citation : Sarikaya S, Ozcan C, Ozturk E and Hamidi N. (2018). Use of Mecsina Hemostopper Tampon as a Hemostatic Agent to Stop Bleeding in Partial Nephrectomy: First Experimental Study in Rats. Mathews J Urol Nephrol 2(1): 009.
Published : 17th September 2018
Authors : Selcuk Sarikaya1,Murat Yildirim2,Cagri Senocak3,Omer Faruk Bozkurt3
Citation : Sarikaya S, Yildirim M, Senocak C and Bozkurt OF. (2018). Severe and Deep Perineal Trauma with a Commando Knife Causing Long Term Erectile Dysfunction. Mathews J Urol Nephrol 2(1): 008.
Published : 06th June 2018
Authors : Eymen Gaze1,Engin Kaya2,Nesrin Turhan3,Metin Yığman4,Mehmet Emin Şirin5,Cavit Ceylan6,Öner Odabaş6
Citation : Gazel E, Kaya E, Turhan N, Yığman M, et all. (2018). Does Immunohistochemical CD47 Staining Intensity Predict Prognozis of Renal Cell Carcinoma Mathews J Urol Nephrol 2(1): 007.
Published : 24th October 2017
Authors : Selçuk Sarıkaya1 *, Rıdvan Özbek2,Çağrı Şenocak2 ,Ömer Faruk Bozkurt2
Citation : Sarıkaya S, Özbek R, Şenocak C and Bozkurtc OF. (2017). Skin Bridges That Occur After Circumcision Operation and Surgical Treatment: Case Presentation. Mathews J Urol Nephrol 1(1): 005.
Published : 24th October 2017
Authors : Selcuk Sarikaya1 *, Mehmet Ciftci2 , Cagri Senocak2 , Ridvan Ozbek D2 , Omer Faruk Bozkurt2
Citation : Sarikaya S, Ciftci M, Senocak C, Ozbek R, et all. (2017). Transobturatory Tape (ToT) for the Treatment Of Stress Urinary İncontinence: Our Experience and Follow-Up Results. Mathews J Urol Nephrol1(1): 006.
Published : 07th October 2017
Author : Selcuk Sarikaya*
Citation : Sarikaya S. (2017). The Role of Scientific Associations in life-long Education for Urologists. Mathews J Urol Nephrol1(1): e002.
Published : 27th September 2017
Authors : Kaiyu Qian1,+, Lei Zheng2,+, Xinyue Cao1 , Yuan Zhu1,3, Yu Xiao1,3,4,*
Citation : Xiao Y, Qian K, Zheng L, Cao X, et al. (2017). Challenges of Ethical Reviews in China’s Biobanks. Mathews J Urol Nephrol 1(1): 004.
Published : 25th August 2017
Author : Selcuk Sarikaya
Citation : Sarikaya S. (2017). A Rare Cause of Penile Fracture: Changing the Electrical Lamp. Mathews J Urol Nephrol 1(1): 003.